Prestige Consumer Healthcare
PBH
NZ$125.26
Share price
-2.16%
Change (1 day)
4.96%
Change (1 year)
Categories
Prestige Consumer Healthcare (PBH) - Net assets
Net assets on the balance sheet as of March 2025 : NZ$3.07 Billion
According to Prestige Consumer Healthcare's latest financial reports the company has NZ$3.07 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Prestige Consumer Healthcare - Net assets on balance sheet (from 2004 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-03-31 | $NZ$2.76 B | 19.65% |
| 2023-03-31 | $NZ$2.31 B | 1.56% |
| 2022-03-31 | $NZ$2.27 B | 16.98% |
| 2021-03-31 | $NZ$1.94 B | -1.15% |
| 2020-03-31 | $NZ$1.96 B | 22.53% |
| 2019-03-31 | $NZ$1.60 B | -1.41% |
| 2018-03-31 | $NZ$1.62 B | 38.88% |
| 2017-03-31 | $NZ$1.17 B | 9.05% |
| 2016-03-31 | $NZ$1.07 B | 27.58% |
| 2015-03-31 | $NZ$0.84 B | 29.83% |
| 2014-03-31 | $NZ$0.64 B | 13.79% |
| 2013-03-31 | $NZ$0.57 B | 16.3% |
| 2012-03-31 | $NZ$0.49 B | 3.14% |
| 2011-03-31 | $NZ$0.47 B | 2.31% |
| 2010-03-31 | $NZ$0.46 B | -10.45% |
| 2009-03-31 | $NZ$0.51 B | -12.87% |
| 2008-03-31 | $NZ$0.59 B | -4.25% |
| 2007-03-31 | $NZ$0.62 B | -8% |
| 2006-03-31 | $NZ$0.67 B | 25.96% |
| 2005-03-31 | $NZ$0.53 B | 183.37% |
| 2004-03-31 | $NZ$0.18 B | 139.27% |
| 2003-03-31 | $NZ$79.2 M | -40.57% |
| 2002-03-31 | $NZ$0.13 B | 14.98% |
| 2001-03-31 | $NZ$0.11 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 GlaxoSmithKline GSK | NZ$29.60 B | 861.48% | 🇬🇧 UK |
 Pfizer PFE | NZ$152.07 B | 4,839.62% | 🇺🇸 USA |
 Rite Aid
RAD | -NZ$3.3 Billion | -207.16% | 🇺🇸 USA |
 Johnson & Johnson JNJ | NZ$131.05 B | 4,156.85% | 🇺🇸 USA |
 Taro Pharmaceutical TARO | NZ$2.98 B | -3.04% | 🇮🇱 Israel |
 Novartis NVS | NZ$64.51 B | 1,995.59% | 🇨🇭 Switzerland |
 Procter & Gamble PG | NZ$88.16 B | 2,763.64% | 🇺🇸 USA |
 CVS Health CVS | NZ$129.38 B | 4,102.41% | 🇺🇸 USA |
 Clorox CLX | NZ$0.31 B | -89.65% | 🇺🇸 USA |
 Abbott Laboratories ABT | NZ$82.32 B | 2,573.93% | 🇺🇸 USA |